| |
| |
|
| Insider
Information: |
Derbyshire Adam C |
| Relationship: |
EVP Finance/CFO |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
218,463 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
218,463 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Salix Pharmaceuticals Ltd |
SLXP |
EVP Finance/CFO |
2014-08-22 |
218,463 |
2006-07-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
189 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-07-20 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-07-21 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-07-22 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-07-23 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-07-24 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-07-27 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-07-28 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-07-29 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-07-30 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-07-31 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-08-03 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-08-04 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-08-05 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-08-06 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-08-07 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-08-10 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-08-11 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-08-12 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-08-13 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-08-14 |
4 |
OE |
$1.13 |
$1,133 |
D/D |
1,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-09-09 |
4 |
OE |
$1.13 |
$5,667 |
D/D |
5,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-09-16 |
4 |
OE |
$1.13 |
$5,667 |
D/D |
5,000 |
109,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-09-30 |
4 |
OE |
$1.13 |
$5,667 |
D/D |
5,000 |
113,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-10-07 |
4 |
OE |
$1.13 |
$5,667 |
D/D |
5,000 |
113,371 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
EVP Finance/CFO |
• – – |
2009-10-14 |
4 |
OE |
$1.13 |
$5,667 |
D/D |
5,000 |
113,371 |
0 |
- |
|
189 Records found
|
|
Page 7 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
